TobaccoReporter logo

Blog

  • South Korea Bans Online Sales of Synthetic Nicotine Vapes

    South Korea Bans Online Sales of Synthetic Nicotine Vapes

    South Korea will ban online sales of liquid e-cigarettes made with synthetic nicotine starting this week, as part of broader regulatory changes under the revised Tobacco Business Act, the finance ministry announced. The update expands the definition of tobacco to include nicotine—whether natural or synthetic—bringing these products under full tobacco regulation.

    Manufacturers and importers will now be required to obtain government approval, register with local authorities, and comply with taxation rules, including a temporary 50% tax reduction for two years. Sales to minors, promotional activities, and product modification for resale will also be prohibited, while use of these products will be banned in designated non-smoking areas.

    The rules also mandate graphic health warnings, ingredient disclosure, and regular testing for harmful substances. Vendors must be licensed as tobacco retailers to sell directly to consumers, while authorities are also reviewing how to regulate emerging “nicotine analog” products not yet formally classified as tobacco.

  • Al Fakher Owner Moves Ahead with Nasdaq Listing

    Al Fakher Owner Moves Ahead with Nasdaq Listing

    Advanced Inhalation Rituals (AIR), the Dubai-based owner of hookah tobacco brand Al Fakher, is proceeding with plans to go public on Nasdaq through a merger with Cantor Equity Partners III, with the deal potentially closing in early May. The company recently submitted its second filing to the U.S. Securities and Exchange Commission, and if approved, the transaction—valuing the combined entity at approximately $1.75 billion—will move to a shareholder vote.

    “The SEC’s declaration of effectiveness of our registration statement is an important regulatory milestone in our journey to become a public company,” said AIR CEO Stuart Brazier, “and we look forward to our planned debut on the Nasdaq as a pure-play social inhalation leader in the coming months.”

    AIR reported 2025 net revenue of $400 million, up 6% year over year, with profits rising to $47 million. The company serves around 14 million consumers globally and operates across 90 markets, with manufacturing facilities spanning the Middle East and Europe. Growth remains driven by expansion in markets such as the U.S., Europe, and Saudi Arabia.

    While operations have not been directly impacted by the ongoing Middle East conflict, supply chains have faced disruption due to the closure of the Strait of Hormuz, increasing logistics costs. The company said it has rerouted shipments and is working to offset higher expenses through cost controls and selective price adjustments, while maintaining its outlook for continued growth in 2026.

  • ATNF Panel Examines State-Level Policy Challenges for Harm Reduction

    ATNF Panel Examines State-Level Policy Challenges for Harm Reduction

    At the American Tobacco and Nicotine Forum (ATNF), a panel moderated by Beth Oliva, a partner at Fox Rothschild, brought together industry, policy, and regulatory experts to examine how state and local policymaking is shaping harm reduction. Panelists Dr. Jeff Willett from the Progressive Policy Institute, Sarah McQuillan from JTI Liggett, Andrew Nunes from PwC, and Laura Leigh Oyler from Haypp Group, repeatedly emphasized a core issue: a widespread lack of understanding among state lawmakers about federal tobacco regulation and the FDA’s role. Several speakers noted that policymakers are often making decisions without a clear grasp of existing frameworks, definitions, or scientific standards, contributing to fragmented and sometimes contradictory regulations.

    A major theme was the disconnect between data and policymaking. Panelists pointed to declining cigarette use alongside growth in alternative products, yet said state responses are often driven more by headlines than evidence. Willett highlighted progress in reducing youth vaping since 2019 and stressed the importance of fact-based policy, while others noted that tax increases, flavor bans, and regulatory gaps can unintentionally push consumers toward illicit markets or cross-border purchases. Nunes and Oyler both underscored how inconsistent tax structures and regulatory approaches across states are distorting markets and complicating compliance for manufacturers and retailers.

    The panel also focused heavily on the growth of illicit markets, with speakers linking it to unmet consumer demand and regulatory gaps. Oyler argued that the lack of authorized products has created a “vacuum” filled by unregulated alternatives, while Willett pointed to evidence that high taxes and restrictions are driving illicit sales in markets like New York. Broader inconsistencies—such as stricter rules for nicotine compared to cannabis or alcohol—were cited as further complicating enforcement and public perception. Panelists warned that states are increasingly reliant on tobacco tax revenue, which can influence policy decisions, and called for more coordinated, evidence-based approaches rather than a patchwork of state-by-state rules.

    Finally, the discussion turned to communication and public health messaging. Speakers argued that the current narrative around nicotine lacks nuance, with limited recognition of the continuum of risk or the role of reduced-risk products. Several panelists called for the FDA to take a more active role in educating both lawmakers and the public, while also stressing the need for better data to be incorporated into legislative debates. Without improved communication and alignment between federal science and state policy, the panel suggested that regulatory fragmentation and market distortions are likely to persist.

    Top of Form

    Bottom of Form

  • UK Passes Tobacco and Vapes Bill to Create ‘Smoke-Free Generation’

    UK Passes Tobacco and Vapes Bill to Create ‘Smoke-Free Generation’

    The UK Parliament has passed the Tobacco and Vapes Bill, introducing a phased ban on cigarette sales to anyone born on or after January 1, 2009, effectively creating a “smoke-free generation.” The legislation also grants ministers new powers to regulate tobacco, vaping, and nicotine products, including controls on flavors, packaging, and marketing.

    The bill expands restrictions on vaping, banning its use in cars carrying children as well as in playgrounds, near schools and at hospitals, while allowing use in certain outdoor and private settings. Smoking and vaping will remain permitted in homes and some outdoor spaces, including hospitality venues.

    Officials described the measure as a major public health intervention aimed at reducing smoking-related harm, while some lawmakers raised concerns about its impact on retailers. Health groups welcomed the legislation and called for additional support for smoking cessation programs, however, critics find the regulation too broad and obtuse.

    “A critically important element of the Tobacco and Vapes Bill is that it gives the government the power to regulate nicotine pouch products,” said Markus Lindblad, head of legal and external affairs at Haypp. “Nicotine pouches do not contain tobacco, nor produce vapor, so they fell outside the scope of existing nicotine product laws. Introducing regulations such as an 18+ age-of-sale and an upper limit of 20mg of nicotine per pouch will help send the message that these products are for adult nicotine users only. Oral nicotine products have enabled Sweden to achieve smoke-free status, and with sensible regulation arising from this Bill, pouches can play a similar role driving down smoking rates in the UK.”

  • PMI Q1 Results Driven by Smoke-Free Growth

    PMI Q1 Results Driven by Smoke-Free Growth

    Philip Morris International reported first-quarter 2026 net revenues of $10.1 billion, up 9.1%, with adjusted diluted EPS rising 16% to $1.96 despite a decline in reported EPS due to a non-cash adjustment. Growth was driven primarily by the company’s smoke-free portfolio, which now accounts for 43% of total revenue and is available in more than 100 markets.

    The smoke-free segment delivered strong performance, with revenue increasing 24.7% and shipment volumes up 11.9%. IQOS remained the key growth driver, with double-digit gains and expanding market share, including becoming the top nicotine brand in markets where it is present. E-vapor products also showed rapid growth, while nicotine pouch volumes expanded in several markets despite declines in Nordic snus.

    Combustible cigarette volumes declined 5.1% in the quarter, although pricing supported modest revenue growth in the segment. Looking ahead, PMI expects continued momentum in smoke-free products, forecasting adjusted EPS growth of 10.9% to 12.9% for 2026 and organic revenue growth of 5% to 7%, supported by ongoing investment in its reduced-risk portfolio.

  • Tennessee Lawmakers Adopt Amendment Strengthening Vape Bill

    Tennessee Lawmakers Adopt Amendment Strengthening Vape Bill

    Tennessee lawmakers approved an amendment to a vape-related bill that expands its scope to more aggressively address youth access and safety concerns, including provisions aimed at tightening controls around vape sales and use tied to incidents in schools. The amendment was backed by bipartisan support, with legislators saying it significantly strengthens the original proposal.

    Rep. Elaine Davis pointed to recent cases at a Knoxville high school where students required medical treatment after vaping, including instances requiring emergency intervention, as evidence of the growing problem. Lawmakers said such incidents are becoming more common across the state, driving urgency for stricter oversight.

    While some legislators raised concerns about regulating adult behavior and potential impacts on local tax revenues, others argued the changes were necessary to address public health risks. Bill sponsor Rep. David Hawk noted implementation challenges with broader restrictions but said further measures could be considered in future sessions. The final vote on the full bill was delayed for additional review.

  • Connecticut House Advances Bill to Limit Vape Shop Growth

    Connecticut House Advances Bill to Limit Vape Shop Growth

    Connecticut lawmakers have approved legislation aimed at reducing the number of smoke and vape shops and strengthening oversight of retailers selling nicotine products. The state House passed the measure 140-3, giving the Department of Consumer Protection expanded authority to deny e-cigarette dealer licenses based on business practices and market saturation.

    Under the bill, regulators could reject license applications if more than 50% of a business’s revenue comes from nicotine-related products or if such products occupy more than 25% of retail space. The proposal also allows the state to deny new licenses in municipalities that already have one dealer per 2,500 residents, while renewal applications would not be subject to this density limit.

  • Malaysian Vape Industry Group Pushes Back on Drug Contamination Claims

    The Malaysian Retail Electronic Cigarette Association (MRECA) raised concerns over reports of vape products containing prohibited substances, while emphasizing that such cases are linked to illicit trade rather than the regulated industry. The group said products approved by the Ministry of Health must meet strict testing and compliance requirements and are distributed through licensed retail channels.

    MRECA said illegal or contaminated products are typically sold through unregulated markets, including unauthorized online platforms, and should not be conflated with compliant offerings. The association also warned about the spread of misleading content on social media, which it said has unfairly implicated legitimate retailers and created confusion about enforcement efforts.

    The group has filed complaints with authorities to address false claims and called for clearer distinctions between regulated products and illicit goods. MRECA said it will continue working with regulators to support enforcement and maintain industry standards.

  • PCA Expands into Asia with Cigraal Partnership

    PCA Expands into Asia with Cigraal Partnership

    The Premium Cigar Association (PCA) announced a strategic partnership with Cigraal to expand its presence in Asia, aiming to support growth and professionalization of the premium cigar sector across key markets, the organization said in a press release. The collaboration will focus on education, regulatory advocacy, and industry engagement in the Asia-Pacific region, the Middle East, and Africa.

    The initiative will launch with PCA Connect Asia, a multi-city program scheduled for November 30 to December 6, featuring training workshops, certification programs and industry events in Hong Kong and Macau. The program will bring together retailers, hospitality operators and industry stakeholders through structured education and networking activities.

    PCA said the partnership reflects growing demand for premium cigars in Asia and the need for stronger industry frameworks to support that expansion. Cigraal, which operates across distribution, retail and brand development, will provide regional expertise to support the rollout of the program.

  • 7th Circuit Upholds Wisconsin Ban on Unauthorized Vape Sales

    7th Circuit Upholds Wisconsin Ban on Unauthorized Vape Sales

    The U.S. Court of Appeals for the Seventh Circuit has ruled that federal law does not preempt Wisconsin’s authority to ban the sale of e-cigarettes that lack FDA authorization, allowing the state to continue enforcing its restrictions. The decision rejects arguments from vaping industry groups that federal tobacco regulations should override state-level controls on product sales and marketing.

    The court found that while the FDA regulates tobacco products at the federal level, states retain the power to impose their own rules on how such products are sold within their borders. The ruling reinforces the ability of states to take independent action against unauthorized vaping products, particularly those that have not received marketing authorization from the FDA.